Mutations in LRRK2 are risk factors for and causes of sporadic and familial Parkinson's disease (PD). LRRK2 is one of the major drug targets for PD. Researchers will be able to observe how this protein works inside cells and more quickly determine how potential drugs affect its function. This will accelerate drug discovery and provide new hope for people with this debilitating disease. Learn more, https://neuros.creative-bi...